rhenium has been researched along with technetium tc 99m medronate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehrhardt, GJ; Englaro, EE; Hertzberg, VS; Maxon, HR; Moulton, JS; Samaratunga, R; Schroder, LE; Smith, H; Thomas, SR; Williams, CC | 1 |
| Ketring, AR | 1 |
| Biersack, HJ; Grünwald, F; Köhler, S; Krebs, D; Palmedo, H; Wagner, U | 1 |
| Becker, W; Behr, TM; Göbel, D; Gratz, S; Herrmann, A | 1 |
| Abrahamsson, PA; Ahlgren, G; Darte, L; Flodgren, P; Garkavij, M; Strand, SE; Tennvall, J | 1 |
| Franke, WG; Hliscs, R; Kropp, J; Liepe, K | 1 |
| Brenner, W; Brümmer, C; Czech, N; Henze, E; Kampen, WU; Muhle, C; von Forstner, C; Zuhayra, M | 1 |
2 trial(s) available for rhenium and technetium tc 99m medronate
| Article | Year |
|---|---|
Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.
Topics: Aged; Bone Neoplasms; Double-Blind Method; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Technetium Tc 99m Medronate | 1991 |
Correlation between radiation dose, synovial thickness, and efficacy of radiosynoviorthesis.
Topics: Arthritis, Rheumatoid; Dose-Response Relationship, Radiation; Erbium; Female; Humans; Immobilization; Joints; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Synovial Membrane; Synovitis; Technetium Tc 99m Medronate; Tissue Distribution; Treatment Outcome; Yttrium Radioisotopes | 1999 |
5 other study(ies) available for rhenium and technetium tc 99m medronate
| Article | Year |
|---|---|
153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.
Topics: Animals; Bone Neoplasms; Dogs; Etidronic Acid; Humans; Kinetics; Organophosphorus Compounds; Pain; Rabbits; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Technetium Tc 99m Medronate; Tissue Distribution | 1987 |
Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Etidronic Acid; Female; Humans; Middle Aged; Palliative Care; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate | 1998 |
Palliative radiation with a radiolabeled diphosphonate (rhenium-186 etidronate) in patients with hormone-refractory disseminated prostate carcinoma.
Topics: Bone Neoplasms; Humans; Male; Pain Management; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Survival Analysis; Technetium Tc 99m Medronate; Treatment Outcome | 2000 |
Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate | 2000 |
Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
Topics: Animals; Bone and Bones; Connective Tissue; Etidronic Acid; Female; Organometallic Compounds; Organophosphorus Compounds; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate; Urinary Bladder; Whole-Body Counting | 2003 |